ESC 365 - Lp(a): should we go after it? Should it modify our lipid targets?

ESC Premium Access

Lp(a): should we go after it? Should it modify our lipid targets?

Session: The Primary Prevention Summit

Topic: Lipids (Epidemiology and Prevention)

Speaker: Professor J. Chapman (Paris, FR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

17 presentations

0 follower

4 more presentations in this session

SPRINT and HOPE3: implications for the treatment of hypertension.

Speaker: Doctor S. Yusuf (Hamilton, CA)

How much exercise is needed to prevent heart disease?

Speaker: Doctor C. Lavie (New Orleans, US)

"Statins for life"? The effect of statins on survival in primary prevention.

Speaker: Professor P. Greenland (Chicago, US)

"Plaque but no obstructive coronary disease" - Primary or secondary prevention?

Speaker: Professor S. Halvorsen (Oslo, NO)

Access the full session

The Primary Prevention Summit

Speakers: Professor J. Chapman, Doctor S. Yusuf, Doctor C. Lavie, Professor P. Greenland, Professor S. Halvorsen

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources